GlassScriptPhysician profile
Jade Y Hon
NPI 1063676260
$23,944.12
in general payments reported to CMS, 2019-2025
54 companies · $4,608 in 2025
The $4,608 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,134 · 2020: $1,161 · 2021: $2,774 · 2022: $3,662 · 2023: $3,959 · 2024: $4,647 · 2025: $4,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,025.25 |
| Education | $188.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,211.51 | 2019-2025 | |
| Ucb, INC. | $1,967.96 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Teva Pharmaceuticals USA, INC. | $1,825.37 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Acadia Pharmaceuticals INC | $1,249.72 | 2019-2025 | Nuplazid, Daybue |
| Amneal Pharmaceuticals LLC | $1,180.99 | 2019-2025 | Crexont, Rytary, Ongentys |
| Mdd US Operations, LLC | $1,099.55 | 2019-2025 | Gocovri, Gocovri |
| Edw Pharma, INC. | $1,030.07 | 2019-2020 | |
| Pfizer INC. | $933.52 | 2019-2025 | |
| Lundbeck LLC | $783.07 | 2019-2025 | Rexulti, Vyepti |
| Neurocrine Biosciences, INC. | $756.36 | 2019-2025 | Ingrezza, Ongentys |
| Axsome Therapeutics, INC. | $607.36 | 2024-2025 | Auvelity, Symbravo |
| Otsuka America Pharmaceutical, INC. | $542.45 | 2023-2025 | Rexulti, Nuedexta |
| Akcea Therapeutics, INC. | $507.12 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $492.69 | 2019-2022 | |
| Sk Life Science, INC. | $454.14 | 2021-2024 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Hon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.